Secondly, an absence of pathological confirmation may fail to provide information regarding prognostic factors such as epidermal growth factor receptor (EGFR) mutation in adenocarcinoma, which is also important in guiding adjuvant therapy [31]. Here, EGFR is linked to adenocarcinoma.